FDA News Digest for March 13, 2006

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: Message

FDA News Digest     

March 13, 2006

________________________________________________________

 

IN THIS WEEK'S ISSUE

»  News

    -- Supplement Makers Warned to Stop Selling Illegal Steroids

    -- Guidelines Aimed at Curbing Entrapment in Hospital Beds

»  Recalls/Safety Alerts

»  Recent Speeches

»  Congressional Testimony

»  Upcoming Public Meetings

»  Question of the Week

________________________________________________________

 

Supplement Makers Warned to Stop Selling Illegal Steroids

FDA has warned the makers and distributors of two unapproved drugs containing steroids that continued sale of these illegal products could result in action such as seizure and injunction. The products, Anabolic Xtreme Superdrol and Methyl 1-P, have been marketed as dietary supplements and promoted for building muscle and strength. However, they may cause serious long-term health problems.

http://www.fda.gov/bbs/topics/NEWS/2006/NEW01332.html

 

Guidelines Aimed at Curbing Entrapment in Hospital Beds

FDA has issued guidelines designed to reduce incidences of patients being caught or trapped between parts of hospital beds. Between January 1985 and January 2006, FDA received 691 reports of such entrapments, 413 of which resulted in death (though the agency suspects these figures are lower than the actual numbers). The guidelines will help families and health care professionals ensure a safe sleeping environment for patients in their care.

http://www.fda.gov/bbs/topics/NEWS/2006/NEW01331.html 

 

To view an archive of past FDA news releases, go to

http://www.fda.gov/opacom/hpnews.html.   

 

To access the RSS feed of FDA news releases, go to

http://www.fda.gov/bbs/topics/news/rssPress.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

________________________________________________________

 

RECALLS/SAFETY ALERTS

 

Food Recalls:

 

Classic Delight's Egg Salad on Vienna Bread, Pilot good to go! sandwiches

    Reason for recall: possible Listeria monocytogenes contamination

http://www.fda.gov/oc/po/firmrecalls/classicdelight03_06.html

 

Maizteca Mexican Bread; 1.5-lb. size

    Reason for recall: undeclared milk

http://www.fda.gov/oc/po/firmrecalls/maizteca03_06.html

 

For a list of recalls, market withdrawals, and safety alerts involving FDA-regulated

products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.

 

To access the RSS feed of FDA recalls information, go to

http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

_________________________________________________________

 

RECENT SPEECHES

 

March 7 -- FDA Deputy Commissioner for Medical and Scientific Affairs Scott Gottlieb, M.D., spoke before the 17th Annual Cancer Progress Conference.

    Subject: biomedical science and cancer treatment

http://www.fda.gov/oc/speeches/2006/cancerprogress0307.html

__________________________________________________

 

CONGRESSIONAL TESTIMONY

 

March 9 -- FDA Center for Food Safety and Applied Nutrition Director Robert E. BrackettPh.D., testified before the House Committee on Government Reform

    Subject: regulation of dietary supplements

http://www.fda.gov/ola/2006/dietsupp0309.html

 

To view an archive of past testimony by FDA officials, go to

http://www.fda.gov/ola/listing.html

__________________________________________________

 

UPCOMING PUBLIC MEETINGS

March 14 -- Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee

    Under discussion: clinical studies of two pediatric oncology drugs

    Location: Gaithersburg, Md.

http://www.fda.gov/oc/advisory/accalendar/2006/cder12542d031406.html

 

March 22 -- Pediatric Advisory Committee

    Under discussion: adverse events reported for attention deficit hyperactivity disorder treatments

    Location: Gaithersburg, Md.

http://www.fda.gov/oc/advisory/accalendar/2006/fda12604d032206amd.html

 

March 23 -- Psychopharmacologic Drugs Advisory Committee

    Under discussion: pending application for a new drug to treat attention deficit hyperactivity disorder

    Location: Gaithersburg, Md.

http://www.fda.gov/oc/advisory/accalendar/2006/cder12544d032306.html

 

April 18-20 -- 2006 FDA Science Forum; includes sessions on drug safety, obesity, avian flu, and non-invasive medical devices. Also planned is a free public session April 18 called "Ask FDA" in which agency scientists will answer questions from consumers about products FDA oversees.

    Location: Washington, D.C.

http://www.fda.gov/scienceforum

 

For a list of FDA meetings, seminars, and other public events, go to

http://www.fda.gov/opacom/hpmeetings.html.

_____________________________________________

 

QUESTION OF THE WEEK

 

How can I find out if a particular laser has been approved to treat my vision problem (nearsightedness, farsightedness, or astigmatism)? 
To find a list of approved devices, their approval dates, and a summary of what they are approved for, go to http://www.fda.gov/cdrh/LASIK/lasers.htm.

_____________________________________________

 

Thanks for subscribing to FDA News Digest. Our next posting will be March 20.

 

To subscribe to or unsubscribe from this list, go to

http://list.nih.gov/cgi-bin/wa?SUBED1=fda-newsdigest-l&A=1

___________________________________________________

 

FDA Centennial logo with slogan

       To learn more about FDA's 100th birthday,

     go to http://www.fda.gov/centennial/default.htm


[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux